vs
Side-by-side financial comparison of Fat Brands, Inc (FAT) and Twist Bioscience Corp (TWST). Click either name above to swap in a different company.
Fat Brands, Inc is the larger business by last-quarter revenue ($140.0M vs $103.7M, roughly 1.4× Twist Bioscience Corp). Twist Bioscience Corp runs the higher net margin — -29.4% vs -41.6%, a 12.2% gap on every dollar of revenue. On growth, Twist Bioscience Corp posted the faster year-over-year revenue change (16.9% vs -2.3%). Fat Brands, Inc produced more free cash flow last quarter ($-16.9M vs $-34.8M).
FAT Brands Inc. is an American multi-brand restaurant and sports bar franchise operator headquartered in Beverly Hills, California.
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
FAT vs TWST — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $140.0M | $103.7M |
| Net Profit | $-58.2M | $-30.5M |
| Gross Margin | — | 52.0% |
| Operating Margin | -12.4% | -31.7% |
| Net Margin | -41.6% | -29.4% |
| Revenue YoY | -2.3% | 16.9% |
| Net Profit YoY | -30.1% | 3.4% |
| EPS (diluted) | $-3.39 | $-0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $103.7M | ||
| Q3 25 | $140.0M | — | ||
| Q2 25 | $146.8M | — | ||
| Q1 25 | $142.0M | — | ||
| Q4 24 | $145.3M | — | ||
| Q3 24 | $143.4M | — | ||
| Q2 24 | $152.0M | — | ||
| Q1 24 | $152.0M | — |
| Q4 25 | — | $-30.5M | ||
| Q3 25 | $-58.2M | — | ||
| Q2 25 | $-54.2M | — | ||
| Q1 25 | $-46.0M | — | ||
| Q4 24 | $-67.4M | — | ||
| Q3 24 | $-44.8M | — | ||
| Q2 24 | $-39.4M | — | ||
| Q1 24 | $-38.3M | — |
| Q4 25 | — | 52.0% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | -31.7% | ||
| Q3 25 | -12.4% | — | ||
| Q2 25 | -10.6% | — | ||
| Q1 25 | -6.0% | — | ||
| Q4 24 | -27.1% | — | ||
| Q3 24 | -6.2% | — | ||
| Q2 24 | -1.8% | — | ||
| Q1 24 | -0.9% | — |
| Q4 25 | — | -29.4% | ||
| Q3 25 | -41.6% | — | ||
| Q2 25 | -36.9% | — | ||
| Q1 25 | -32.4% | — | ||
| Q4 24 | -46.4% | — | ||
| Q3 24 | -31.2% | — | ||
| Q2 24 | -25.9% | — | ||
| Q1 24 | -25.2% | — |
| Q4 25 | — | $-0.50 | ||
| Q3 25 | $-3.39 | — | ||
| Q2 25 | $-3.17 | — | ||
| Q1 25 | $-2.73 | — | ||
| Q4 24 | $-4.06 | — | ||
| Q3 24 | $-2.74 | — | ||
| Q2 24 | $-2.43 | — | ||
| Q1 24 | $-2.37 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $197.9M |
| Total DebtLower is stronger | $1.3B | — |
| Stockholders' EquityBook value | $-585.8M | $456.1M |
| Total Assets | $1.2B | $638.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $197.9M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.3B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.2B | — | ||
| Q1 24 | $1.2B | — |
| Q4 25 | — | $456.1M | ||
| Q3 25 | $-585.8M | — | ||
| Q2 25 | $-536.5M | — | ||
| Q1 25 | $-493.9M | — | ||
| Q4 24 | $-455.7M | — | ||
| Q3 24 | $-386.1M | — | ||
| Q2 24 | $-338.6M | — | ||
| Q1 24 | $-296.8M | — |
| Q4 25 | — | $638.1M | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $1.4B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-14.5M | $-24.8M |
| Free Cash FlowOCF − Capex | $-16.9M | $-34.8M |
| FCF MarginFCF / Revenue | -12.1% | -33.5% |
| Capex IntensityCapex / Revenue | 1.7% | 9.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-75.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-24.8M | ||
| Q3 25 | $-14.5M | — | ||
| Q2 25 | $-26.9M | — | ||
| Q1 25 | $-13.2M | — | ||
| Q4 24 | $-10.4M | — | ||
| Q3 24 | $-3.2M | — | ||
| Q2 24 | $-14.2M | — | ||
| Q1 24 | $-28.4M | — |
| Q4 25 | — | $-34.8M | ||
| Q3 25 | $-16.9M | — | ||
| Q2 25 | $-29.3M | — | ||
| Q1 25 | $-17.8M | — | ||
| Q4 24 | $-11.0M | — | ||
| Q3 24 | $-11.1M | — | ||
| Q2 24 | $-24.4M | — | ||
| Q1 24 | $-32.5M | — |
| Q4 25 | — | -33.5% | ||
| Q3 25 | -12.1% | — | ||
| Q2 25 | -20.0% | — | ||
| Q1 25 | -12.5% | — | ||
| Q4 24 | -7.6% | — | ||
| Q3 24 | -7.7% | — | ||
| Q2 24 | -16.1% | — | ||
| Q1 24 | -21.4% | — |
| Q4 25 | — | 9.6% | ||
| Q3 25 | 1.7% | — | ||
| Q2 25 | 1.6% | — | ||
| Q1 25 | 3.2% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 5.5% | — | ||
| Q2 24 | 6.7% | — | ||
| Q1 24 | 2.7% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FAT
| Restaurant Sales | $96.6M | 69% |
| Royalty | $21.6M | 15% |
| Factory | $9.6M | 7% |
| Advertising | $9.1M | 7% |
| Franchisor | $1.5M | 1% |
| Other | $1.5M | 1% |
TWST
| Industrial Chemicals | $37.2M | 36% |
| Diagnostics | $35.3M | 34% |
| Food Or Agriculture | $12.8M | 12% |
| Academic Research | $12.2M | 12% |
| Health Care | $6.1M | 6% |
